AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Evaluation, Treatment, and Follow-up of Patients With Lyme Disease

Recruitingn/aAges 2 Years - 99 YearsAllNational Institute of Allergy and Infectious Diseโ€ฆ
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study is designed to establish a population of patients with Lyme disease for evaluation, treatment and follow-up to learn more about the infection. Patients with active Lyme disease may be eligible for this study. Participants will have a medical history and physical examination and diagnostic evaluations as appropriate to their individual condition. Laboratory tests may include routing blood and urine tests, X-rays, or other imaging studies, body fluid or tissue cultures, skin biopsy and tests for allergic or immune responses. Treatment will include only medications approved by the Food and Drug Administration, given according to accepted dose schedules and ways of taking the medicines. All diagnostic tests and treatments will be according to standard medical practice for the disease. No experimental procedures will be offered under this protocol. Patients will be followed as n

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
* INCLUSION CRITERIA: * Clinical diagnosis of active Lyme disease at the time of the initial NIH evaluation based on the CDC case definition. Study physician will review history to confirm probable cases. * Subjects must maintain a private physician for non-protocol related medical complaints and for emergency medical treatment required for these or other of their disorders. EXCLUSION CRITERIA: * Post treatment Lyme disease syndrome. * Unacceptably poor compliance, which, in the opinion of the investigator, would interfere with one's ability to study or provide quality medical care for the patient. ELIGIBILITY CRITERIA TO BE ASKED TO UNDERGO APHERESIS INCLUDE: * Age 18 years or above * Weight greater than 110 pounds * No known heart, lung, kidney disease, or bleeding disorders * Negative HIV, HCV and HBsAg serologies * Female subjects should not be pregnant or nursing * Adequate peripheral venous access Patients will have a CBC performed up to 2 weeks before the procedure. In order to be able to undergo the procedure, patient must fulfill all of the below: * Hemoglobin greater than 11 g/dL for males and greater than 10 g/dL for females * Platelets greater than 150 k/mm(3) * WBC greater than 3.5 x 10(3) uL * MCV above 80 Women who are able to conceive children must have a negative pregnancy test within 2 weeks before the procedure.
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
National Institutes of Health Clinical Center
Bethesda, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy